Previous 10 | Next 10 |
CLEVELAND , July 16, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of Dr. Gail Wilensky to its Board of Directors, effective today. Dr. Wilensky has an extensive track record in healthcare as a policy leader, reimbursement expert, and board member....
CLEVELAND , July 10, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® System is the focus of more than 40 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2019 Annual Meetin...
CLEVELAND , May 22, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the clinical team at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has treated its 1,000 th patient using MRIdian MR-guide...
CLEVELAND , May 16, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in the Jefferies 2019 Global Healthcare Conference in New York, New York . Scott Drake , President and CEO, will participate in a fireside chat at 8:30 a.m. East...
Quick Take Varian ( VAR ) announced it has acquired CyberHeart for an undisclosed amount. CyberHeart has intellectual property that covers cardiac radioablation - the use of radiation to scar or destroy tissue in the heart that is facilitating faulty electrical signals, causing an abnorm...
Biotech Stocks: Global Revenues For Ophthalmology Market Projected To Reach $26 Billion By 2022 May 9, 2019 Palm Beach, FL –May 9, 2019 – As the baby boomer generation ages, there is an increased need… no… a demand by these aging patients to avert vision and...
ViewRay, Inc. (VRAY) Q1 2019 Earnings Conference Call May 02, 2019 4:30 PM ET Company Participants Michaella Gallina – Senior Director, Investor Relations and Communications Scott Drake – President and Chief Executive Officer Ajay Bansal – Chief Financial Off...
ViewRay ( VRAY +18.6% ) is up on below-average volume in early trade after posting Q1 results after the close yesterday that came in shy of consensus. More news on: ViewRay, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...
ViewRay (NASDAQ: VRAY ): Q1 GAAP EPS of -$0.34 misses by $0.13 . More news on: ViewRay, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
CLEVELAND , May 2, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2019 . First Quarter 2019 Highlights: Received 7 new orders for MRIdian systems totaling $42.8 million , compared to 3 orders...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...